Alkem Laboratories Ltd 16 Feb 2026 12:00 AM
USFDA completes inspection of Enzene`s manufacturing unit at Chakan, Pune,
Alkem Laboratories announced that the United States Food and Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) on 13 February, 2026 at the manufacturing facility of Enzene Biosciences (Enzene), a subsidiary of the Company in India located at Chakan, Pune. At the conclusion of the inspection, the USFDA issued a Form 483 with 6 procedural observations. Enzene has achieved Zero observations related to data integrity - a critical validation of Enzene`s quality systems and the reliability of regulatory filings. Enzene is in the process of preparing and submitting its response to the USFDA within the stipulated timeline and has initiated appropriate corrective and preventive actions. Powered by Capital Market - Live News
Alkem Laboratories Ltd 13 Feb 2026 12:00 AM
Board of Alkem Laboratories recommends interim dividend,
Alkem Laboratories announced that the Board of Directors of the Company at its meeting held on 13 February 2026, inter alia, have recommended the interim dividend of Rs 43 per equity Share (i.e. 2150%) , subject to the approval of the shareholders.Powered by Capital Market - Live News
Alkem Laboratories Ltd 13 Feb 2026 12:00 AM
Alkem Laboratories consolidated net profit rises 1.63% in the December 2025 quarter,
Net profit of Alkem Laboratories rose 1.63% to Rs 636.02 crore in the quarter ended December 2025 as against Rs 625.82 crore during the previous quarter ended December 2024. Sales rose 10.74% to Rs 3736.82 crore in the quarter ended December 2025 as against Rs 3374.28 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3736.823374.28 11 OPM %22.1622.51 - PBDT929.00816.35 14 PBT833.99731.07 14 NP636.02625.82 2 Powered by Capital Market - Live News
Alkem Laboratories Ltd 24 Jan 2026 12:00 AM
Alkem Laboratories to table results,
Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News
Alkem Laboratories Ltd 08 Jan 2026 12:00 AM
Alkem launches Renocia cyclical therapy kit for hair care,
Alkem Laboratories announced the launch of Renocia cyclical therapy kit, a scientifically-designed weekly nutritional supplementation regimen to support hair growth, strengthen hair follicles and manage hair loss. The supplements in the kit are made using only vegetarian-sourced ingredients. Renocia cyclical therapy kit contains a set of nutritional supplements, including vitamins, minerals, and amino acids, each to be taken on designated days of the week. This structured weekly protocol enables better nutrient absorption and utilisation. Alkem has a growing portfolio of products in the dermatology segment, which includes skin and hair care. Under the Renocia brand, the company offers several products for hair care such as hair revitalizing shampoo, conditioner and serum, as well as oral supplements. Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now